A blood test that draws on AI will be able to foresee whether someone cause Parkinson's disease in their old age

Parkinson’s disease is the world’s fastest growing neurodegenerative condition, a trend driven primarily by the ageing population. It was said on a report that Artificial Intelligence (AI) can predict Parkinson’s disease up to seven years before symptoms develop in a person.

A blood test that draws on AI will be able to foresee whether someone cause Parkinson’s disease in their old age. The test is designed to work on equipment already found in many NHS laboratories and, corroborated in a broad population of people which could be made available to the health service within two years.

Also, read| Viagra May Prevent Dementia: Oxford Study

Currently, there is no drug to protect the  brain from Parkinson’s disease, but an accurate predictive test would enable clinics to identify people who stand to benefit most from clinical trials of treatments intend to halt the disease.

According to the Reports, Prof Kevin Mills, a senior author on the study at UCL Great Ormond Street Institute of child Health said, “At the moment , we are shutting the stable door after the horse has bolted, we need  to get to people before they develop symptoms. It is always better to prevent than cure.”

This disorder affects more than 150,000 people in the UK and 10  million worldwide. It is caused by the buildup of a protein called alpha-synuclein that damages or destroys nerve cells which produce an important substance called dopamine in part of the brain called the substantia nigra.

Parkinson’s can experience tremors difficulties with movement and muscles stuffiness, but also problems with balance, memory, dizziness and nerve pain. To cure this, many receive dopamine replacement therapy, but efforts are under way to seek treatments that slow or gradually stop the disease.

Prof Roger Barker, a consultant neurologist who specialises in Parkinson’s at the University of Cambridge and Addenbrooke’s hospital stated, ” If validated by other groups, the test raised the possibility of diagnosing Parkinson’s at the very early stages, enabling patients to be enrolled in clinical trials when the disease process had just begun.”

Also, read| Australia Reports Its First Avian Influenza In Human

“As such, we could we could treat people with disease modifying therapies before they have lost many  brain cells, obviously, we still need to find such therapies but this study is a step in the right direction,” he added.

Most of the scientists who are in this new medical experiment say new early diagnosis method could improve research into treatment aiming to slow down the disease or prevent in from causing the nerves in a panoptic way.

(With inputs from The Guardian)